Jose Henrique Pilotto Selected Research

Jose Henrique Pilotto Research Topics

5	HIV Infections (HIV Infection) 01/2022 - 06/2012
4	Infections 01/2022 - 06/2012
4	Tuberculosis (Tuberculoses) 01/2022 - 01/2019
2	Immune Reconstitution Inflammatory Syndrome 01/2022 - 01/2020
2	Sexually Transmitted Diseases (Sexually Transmitted Disease) 11/2021 - 02/2007
2	Coinfection 02/2020 - 12/2017
1	Disease Progression 10/2023
1	Reinfection 10/2023
1	COVID-19 10/2023
1	Inflammation (Inflammations) 02/2020
1	Viremia 02/2020
1	Syphilis 01/2018
1	Zika Virus Infection 09/2017
1	Dengue (Dengue Fever) 09/2017

3	DNA (Deoxyribonucleic Acid)IBA 02/2020 - 12/2017
2	Biomarkers (Surrogate Marker)IBA 10/2023 - 02/2020
2	AntibodiesIBA 01/2018 - 09/2017
1	VaccinesIBA 10/2023
1	Neutralizing AntibodiesIBA 10/2023
1	CytokinesIBA 01/2022
1	InflammasomesIBA 01/2022
1	insulin receptor-related receptor (IRR)IBA 11/2021
1	Integrase InhibitorsIBA 02/2020
1	efavirenz (Sustiva)FDA Link 02/2020
1	Raltegravir Potassium FDA Link 02/2020
1	Genetic Markers (Genetic Marker)IBA 01/2020
1	HLA-B Antigens (HLA-B)IBA 01/2020
1	HLA-C Antigens (HLA-C)IBA 01/2020
1	lipoarabinomannan (LAM)IBA 01/2019
1	Immunoglobulin G (IgG)IBA 09/2017
1	RNA (Ribonucleic Acid)IBA 09/2017
1	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 10/2015
1	Nelfinavir (Viracept)FDA Link 06/2012
1	Lamivudine (Epivir)FDA Link 06/2012
1	Nevirapine (Viramune)FDA Link 06/2012
1	Zidovudine (Retrovir)FDA LinkGeneric 06/2012

2	Art Therapy 02/2020 - 06/2012
1	Immunotherapy 10/2023
1	Length of Stay 10/2023
1	Therapeutics 02/2020
1	Highly Active Antiretroviral Therapy (HAART) 10/2018
1	Ambulatory Care (Outpatient Care) 02/2007